Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
64.96
2.24 (3.57%)
At close: Sep 26, 2025, 3:59 PM
64.76
-0.31%
After-hours: Sep 26, 2025, 04:54 PM EDT
Soleno Therapeutics Revenue Breakdown
| Period Ending | Jun 30, 2025 |
|---|---|
| Product Revenue | 32.66M |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.24M | 29.26M | 37.3M | 49.2M | 10.39M | 8.47M | 3.65M | 3.32M | 3.17M | 2.85M | 2.4M | 2.33M | 2.47M | 2.64M | 2.6M | 2.77M | 2.46M | 2.98M | 2.25M | 2.26M | 2.25M | 2M | 1.61M | 1.61M | 1.7M | 2.01M | 1.36M | 1.56M | 1.77M | 1.87M | 1.68M | 1.71M | 2.19M | 1.27M | 2.06M | 1.74M | 2.09M | 2.48M | 2.21M | 2.18M | 1.94M | 1.55M |
| Selling, General, and Administrative Revenue Growth | -3.49% | -21.56% | -24.18% | +373.28% | +22.70% | +132.05% | +10.04% | +4.70% | +11.04% | +18.82% | +3.00% | -5.47% | -6.66% | +1.81% | -6.18% | +12.30% | -17.29% | +32.34% | -0.22% | +0.36% | +12.23% | +24.56% | -0.43% | -4.72% | -15.76% | +47.40% | -12.39% | -11.78% | -5.41% | +10.84% | -1.33% | -22.23% | +72.56% | -38.37% | +18.61% | -16.59% | -15.79% | +12.22% | +1.21% | +12.54% | +24.87% | n/a |
| Research and Development Revenue | 9.15M | 13.52M | 21.49M | 30.14M | 12.34M | 14.6M | 8.69M | 6.04M | 5.14M | 5.32M | 3.81M | 3.77M | 3.7M | 3.99M | 3.73M | 4.97M | 5.59M | 7.16M | 5.57M | 4.83M | 6.1M | 6.7M | 5.27M | 4.49M | 3.75M | 2.76M | 2.19M | 2.09M | 1.71M | 1.18M | 1.02M | 982K | 974K | 994K | 953.8K | 1.13M | 1.33M | 1.77M | 1.28M | 1.19M | 1.18M | 878K |
| Research and Development Revenue Growth | -32.33% | -37.09% | -28.71% | +144.19% | -15.48% | +68.05% | +43.79% | +17.55% | -3.29% | +39.53% | +1.03% | +2.03% | -7.32% | +6.80% | -24.84% | -11.08% | -22.01% | +28.71% | +15.31% | -20.91% | -8.84% | +26.99% | +17.42% | +19.89% | +35.69% | +25.91% | +4.78% | +22.05% | +45.25% | +15.38% | +4.15% | +0.82% | -2.01% | +4.21% | -15.67% | -14.77% | -25.11% | +37.98% | +7.65% | +1.02% | +34.51% | n/a |